NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, May 8th. Shareholders of record on Friday, June 1st will be paid a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date is Thursday, May 31st. This is a positive change from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.

Baxter International announced that its board has initiated a stock buyback plan on Wednesday, February 21st 2018, which permits the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) released its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 EPS for the quarter, beating the consensus estimate of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to the consensus estimate of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The business's quarterly revenue was up 8.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.58 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 brokers have issued 1-year target prices for Baxter International's stock. Their predictions range from $62.00 to $83.00. On average, they expect Baxter International's stock price to reach $72.7333 in the next twelve months. View Analyst Ratings for Baxter International.

Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), FRESENIUS SE &/S (FSNUY), Boston Scientific (BSX), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Insulet (PODD), Globus Medical (GMED), Penumbra (PEN) and Haemonetics (HAE).

News coverage about BAX stock has trended somewhat positive on Monday, Accern reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Baxter International earned a media sentiment score of 0.17 on Accern's scale. They also assigned press coverage about the medical instruments supplier an impact score of 46.29 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.05%), Veritas Asset Management LLP (1.77%), Northern Trust Corp (1.65%), Wells Fargo & Company MN (1.07%), Old Mutual Global Investors UK Ltd. (0.65%) and Legal & General Group Plc (0.53%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN, Aristotle Capital Management LLC, CI Global Investments Inc., Veritas Asset Management LLP and Northern Trust Corp. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was purchased by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., Point72 Asset Management L.P., The Manufacturers Life Insurance Company, Natixis, Old Mutual Global Investors UK Ltd., BNP Paribas Arbitrage SA, Mackay Shields LLC and Eaton Vance Management. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $73.74.

Baxter International has a market capitalization of $39.80 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]